小児用カテーテルの世界市場：2024～2031年

概要

世界の小児用カテーテル市場は2023年に65億米ドルに達し、2031年には113億米ドルに達すると予測され、予測期間2024-2031年にはCAGR7.3%で成長します。

小児用カテーテルは、新生児や小児に適したサイズ尿道カテーテルです。小児カテーテルは、新生児や小児に適したサイズ尿道カテーテルです。カテーテルはヘルスケア専門家によって処方される医療機器です。

これらカテーテルは、患者に薬物、液体、気体を供給したり、尿など体液を排出したりするために使用される高級材料で作られています。小児用カテーテルは導尿カテーテルとしても知られています。

小児用カテーテル市場は、小児泌尿器疾患有病率増加、カテーテル技術的進歩、低侵襲外科手術需要増加など要因によって、医療機器産業急成長分野となっています。

市場力学

促進要因

小児人口の増加と尿路感染症の有病率の増加

世界の小児用カテーテル市場の需要は、複数の要因によって牽引されています。市場を牽引する主な要因の1つは、小児人口の増加と尿路感染症の有病率の増加です。

尿路感染症（UTI）は最も一般的な小児感染症の1つです。2024年の泌尿器ケア財団によると、尿路感染症とは、細菌が尿に混入し、膀胱まで移動することです。女児では100人に8人、男児では100人に2人が尿路結石にかかるとされています。

2024年1月のMedSpaceの発表によると、男児の尿路結石の発生率は女児を上回り、初回および再発の尿路結石は女児に最も多いです。1-2歳の小児における尿路結石の発生率は、女児で8.1％、男児で1.9％です。

さらに、泌尿器系および心臓血管系への介入を必要とする小児患者の増加により、小児用カテーテル市場の需要拡大が見込まれています。

さらに、新興企業やカテーテル設計の革新といった業界戦略の主要企業が、この市場成長を後押しすると思われます。例えば、2022年7月、アラバマ大学バーミンガム校とアラバマ小児医療センター（Children's of Alabama）を横断する専門家グループが地元の起業家とともに、UAB Harbert Institute for Innovation and Entrepreneurshipの最新スタートアップであるZorro-Flow Inc.を立ち上げました。

この製品は、重症の女性新生児や1歳未満の乳児の尿を安全かつ効果的に採取するために設計された新生児用外尿採取装置です。

抑制要因

製品リコール、カテーテルの高コスト、小児患者のカテーテル治療に伴う合併症のリスク、認知度の不足、小児科医の高コスト、限定的な償還政策などの要因が市場の妨げになると予想されます。

目次

第1章 調査手法と調査範囲

第2章 定義と概要

第3章 エグゼクティブサマリー

第4章 市場力学

• 影響要因
  • 促進要因
    • 小児人口の増加と尿路感染症の有病率の増加
    • カテーテル設計の技術的進歩
    • 小児科における低侵襲手術に対する需要の高まり
  • 抑制要因
    • 製品回収
    • カテーテルの高コスト
  • 機会
  • 影響分析

第5章 産業分析

• ポーターのファイブフォース分析
• サプライチェーン分析
• 価格分析
• 規制分析
• アンメットニーズ
• PESTEL分析
• 特許分析
• SWOT分析

第6章 COVID-19分析

第7章 製品タイプ別

• 静脈カテーテル
• 心血管カテーテル
• 泌尿器カテーテル
• 神経血管カテーテル
• 特殊カテーテル

第8章 材料タイプ別

• ポリ塩化ビニル（PVC）
• シリコーン
• ポリウレタン
• その他の材料

第9章 エンドユーザー別

• 病院
• 外来手術センター
• 専門クリニック

第10章 地域別

• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • ドイツ
  • 英国
  • フランス
  • イタリア
  • スペイン
  • その他欧州
• 南米
  • ブラジル
  • アルゼンチン
  • その他南米
• アジア太平洋
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• 中東・アフリカ

第11章 競合情勢

• 競合シナリオ
• 市況/シェア分析
• M&A分析

第12章 企業プロファイル

• Medtronic Inc
  • 会社概要
  • 製品ポートフォリオと説明
  • 財務概要
  • 主な発展
• BD
• Smiths Medical
• Edwards Lifesciences Corporation
• Cook Medical
• Cardinal Health
• Coloplast
• CIA Medical
• Getinge
• Medical, Inc

第13章 付録

Overview

The global pediatric catheters market reached US$ 6.5 billion in 2023 and is expected to reach US$ 11.3 billion by 2031, growing at a CAGR of 7.3% during the forecast period 2024-2031.

Pediatric catheters are urinary catheters that come in sizes suitable for newborns or children. They are designed to address the difficulties related to catheterization in children. Catheters are medical devices prescribed by healthcare professionals.

These catheters are made from high-grade materials used for delivering medications, fluids, and gases to patients or draining bodily fluids such as urine. Pediatric catheters are also known as urinary catheters

The pediatric catheters market is a rapidly growing segment of the medical device industry, driven by factors such as the increasing prevalence of pediatric urological conditions, technological advancements in catheters, and the growing demand for minimally invasive surgical procedures.

Market Dynamics

Drivers

Rising Pediatric Population & Increasing Prevalence of Urinary Tract Infections

The demand for the global pediatric catheter market is driven by multiple factors. One of the key factors driving the market is the rising pediatric population & increasing prevalence of urinary tract infections.

Urinary tract infection (UTI) is one of the most common pediatric infections. According to the Urology Care Foundation in 2024, a UTI is when bacteria gets into your urine and travels up to your bladder. As many as 8 in 100 girls and 2 in 100 boys will get UTIs.

As per MedSpace publication in January 2024, the incidence of UTI in boys exceeds that in girls, first-time & recurrent UTIs are most common in girls. The incidence of UTI in children aged 1-2 years is 8.1% in girls and 1.9% in boys.

Moreover, an increasing number of pediatric patients requiring urological and cardiovascular interventions are expected to grow the demand for the pediatric catheter market.

In addition, key players in the industry strategies such as start-ups and innovations in catheter design would drive this market growth. For instance, in July 2022, a group of experts from across the University of Alabama at Birmingham and Children's of Alabama, along with local entrepreneurs, launched Zorro-Flow Inc., the newest startup of the UAB Harbert Institute for Innovation and Entrepreneurship.

The product is a neonatal external urine-collection device designed to collect urine safely and effectively in critically ill female neonates and infants under 1 year old.

Restraints

Factors such as product recalls, the high cost of the catheters, the risk of complications associated with catheterization in pediatric patients, lack of awareness, high cost for pediatric doctors, and limited reimbursement policies, are expected to hamper the market.

For more details on this report - Request for Sample

Segment Analysis

The global pediatric catheters market is segmented based on product type, material type, end-user, and region.

The cardiovascular catheters segment accounted for approximately 43.3% of the global pediatric catheters market share

The cardiovascular catheters segment is expected to hold the largest market share over the forecast period. Cardiac catheterization is a nonsurgical, minimally invasive procedure in which a doctor threads thin, flexible tubes called catheters into a blood vessel and guides it to the heart. Cardiac catheterization can help diagnose and treat a variety of congenital and acquired heart conditions in pediatrics.

Moreover, government initiations, technological advancements, and product approvals would drive this segment's growth. For instance, in February 2023, the Ministry of Health announced the opening of the first pediatric cardiac catheterization ward in the governmental health sector in Palestine at the Palestine Medical Complex in Ramallah.

Also, in February 2022, a new larger, and more technologically advanced catheterization laboratory at Children's of Mississippi is allowing the children's hospital's smallest patients to get the cardiac diagnostic care and treatment they need.

Similarly, in, February 2022, Medtronic plc announced that the Freezor and Freezor Xtra Cardiac Cryoablation Focal Catheters are the first and only ablation catheters approved by the U.S. Food and Drug Administration (FDA) to treat the growing prevalence of pediatric Atrioventricular Nodal Reentrant Tachycardia (AVNRT).

Geographical Analysis

North America accounted for approximately 42.6% of the global pediatric catheters market share

North America region is expected to hold the largest market share over the forecast period owing to the growing prevalence of congenital heart defects, urological problems, and rising inpatient and emergency room procedures.

Moreover, governments worldwide have implemented several initiatives to extend medical coverage to a large number of previously uninsured individuals. For instance, programs like the Child Health Insurance Program (CHIP) in the U.S. have been established to offer year-long healthcare coverage specifically to children. These initiatives are expected to have a positive impact on the adoption of pediatric catheters over the forecast period.

In addition, advanced healthcare infrastructure, technological innovations, product approvals, and favorable federal initiatives for the development of pediatric catheters are likely to boost the market in North America. For instance, in November 2023, BD launched its new needle-free blood draw technology, PIVO Pro, with FDA clearance. This innovative solution was compatible with integrated catheters, supporting BD's vision of a "One-Stick Hospital Stay." It aimed to reduce needlesticks, improve patient experience, and enhance clinical outcomes.

Also, in November 2023, CorMedix Inc. announced FDA approval of DefenCath to reduce the incidence of catheter-related bloodstream infections in adult hemodialysis patients.

COVID-19 Impact Analysis

The COVID-19 pandemic significantly impacted the global pediatric catheter market. The COVID-19 pandemic has posed tremendous stress on the healthcare system. Its effects on pediatric/congenital catheterization program practice and performance have not been described

According to the Annals of Pediatric Cardiology research publications in October 2021, the reduction in the number of hospitalizations, cardiac surgeries, and catheterization procedures was 66.8%, 73.0%, and 74.3%, respectively.

The reduction in hospitalization was relatively less pronounced among neonates as compared to infants/children and for emergency surgeries as compared to elective indications. The overall in-hospital mortality was higher in 2020 (8.1%) as compared to 2019 (4.8%), with a higher postoperative mortality.

From the same source, 91.2% of the hospitals have canceled elective surgeries. The number of cardiac catheterization procedures for CHD also decreased and all elective cases were canceled among US hospitals.

Congenital cardiac care plummeted across all the age groups, but the comparative outreach for neonatal cardiac care suffered the least, probably because the essential maternal child health and neonatal care services functioned optimally even during the lockdown period in India.

Market Segmentation

By Product Type

• Intravenous Catheters
• Cardiovascular Catheters
• Urology Catheters
• Neurovascular Catheters
• Specialty Catheters

By Material Type

• Polyvinyl Chloride (PVC)
• Silicone
• Polyurethane
• Other Materials

By End User

• Hospitals
• Ambulatory Surgery Centers
• Specialty Clinics

By Region

• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • U.K.
  • France
  • Spain
  • Italy
  • Rest of Europe
• South America
  • Brazil
  • Argentina
  • Rest of South America
• Asia-Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Middle East and Africa

Competitive Landscape

The major global players in the pediatric catheter market include Medtronic Inc., BD, Smiths Medical, Edwards Lifesciences Corporation, Cook Medical, Cardinal Health, Coloplast, CIA Medical, Getinge, and 180 Medical, Inc. among others.

Key Developments

• In March 2024, Cook Medical announces a new pediatric indication for the shorter liver access biopsy set. These catheters are used in angiographic procedures, diagnostic procedures, and vascular interventions to make sure medical devices are sized correctly.
• In March 2024, CoapTech, Inc. announces the launch of its Second-Generation Magnetic Balloon Catheter for the PUMA-G System. PUMA-G Pediatrics, where smaller magnets aid in navigating a catheter through a child's relatively small gastrointestinal tract anatomy.

Why Purchase the Report?

• To visualize the global pediatric catheter market segmentation based on product type, material type, end-user, and region as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development
• Excel data sheet with numerous data points of global pediatric catheter market level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping is available in excel consisting of key products of all the major players.

The global pediatric catheters market report would provide approximately 62 tables, 55 figures, and 181 Pages.

Target Audience 2024

• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies

Table of Contents

1. Methodology and Scope

• 1.1. Research Methodology
• 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

• 3.1. Snippet by Product Type
• 3.2. Snippet by Material Type
• 3.3. Snippet by End-User
• 3.4. Snippet by Region

4. Dynamics

• 4.1. Impacting Factors
  • 4.1.1. Drivers
    • 4.1.1.1. Rising Pediatric Population & Increasing Prevalence of Urinary Tract Infections
    • 4.1.1.2. Technological Advancements in the Catheter Design
    • 4.1.1.3. Growing Demand for Minimally Invasive Surgical Procedures in Pediatrics
  • 4.1.2. Restraints
    • 4.1.2.1. Product Recalls
    • 4.1.2.2. The High Cost of Catheters
  • 4.1.3. Opportunity
  • 4.1.4. Impact Analysis

5. Industry Analysis

• 5.1. Porter's Five Force Analysis
• 5.2. Supply Chain Analysis
• 5.3. Pricing Analysis
• 5.4. Regulatory Analysis
• 5.5. Unmet Needs
• 5.6. PESTEL Analysis
• 5.7. Patent Analysis
• 5.8. SWOT Analysis

6. COVID-19 Analysis

• 6.1. Analysis of COVID-19
  • 6.1.1. Scenario Before COVID
  • 6.1.2. Scenario During COVID
  • 6.1.3. Scenario Post COVID
• 6.2. Pricing Dynamics Amid COVID-19
• 6.3. Demand-Supply Spectrum
• 6.4. Government Initiatives Related to the Market During the Pandemic
• 6.5. Manufacturers Strategic Initiatives
• 6.6. Conclusion

7. By Product Type

• 7.1. Introduction
  • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 7.1.2. Market Attractiveness Index, By Product Type
• 7.2. Intravenous Catheters *
  • 7.2.1. Introduction
  • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 7.3. Cardiovascular Catheters
• 7.4. Urology Catheters
• 7.5. Neurovascular Catheters
• 7.6. Specialty Catheters

8. By Material Type

• 8.1. Introduction
  • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material Type
  • 8.1.2. Market Attractiveness Index, By Material Type
• 8.2. Polyvinyl Chloride (PVC) *
  • 8.2.1. Introduction
  • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 8.3. Silicone
• 8.4. Polyurethane
• 8.5. Other Materials

9. By End-User

• 9.1. Introduction
  • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 9.1.2. Market Attractiveness Index, By End-User
• 9.2. Hospitals *
  • 9.2.1. Introduction
  • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 9.3. Ambulatory Surgical Centers
• 9.4. Specialty Clinics

10. By Region

• 10.1. Introduction
  • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
  • 10.1.2. Market Attractiveness Index, By Region
• 10.2. North America
  • 10.2.1. Introduction
  • 10.2.2. Key Region-Specific Dynamics
  • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material Type
  • 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 10.2.6.1. U.S.
    • 10.2.6.2. Canada
    • 10.2.6.3. Mexico
• 10.3. Europe
  • 10.3.1. Introduction
  • 10.3.2. Key Region-Specific Dynamics
  • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material Type
  • 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 10.3.6.1. Germany
    • 10.3.6.2. UK
    • 10.3.6.3. France
    • 10.3.6.4. Italy
    • 10.3.6.5. Spain
    • 10.3.6.6. Rest of Europe
• 10.4. South America
  • 10.4.1. Introduction
  • 10.4.2. Key Region-Specific Dynamics
  • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material Type
  • 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 10.4.6.1. Brazil
    • 10.4.6.2. Argentina
    • 10.4.6.3. Rest of South America
• 10.5. Asia-Pacific
  • 10.5.1. Introduction
  • 10.5.2. Key Region-Specific Dynamics
  • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material Type
  • 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 10.5.6.1. China
    • 10.5.6.2. India
    • 10.5.6.3. Japan
    • 10.5.6.4. South Korea
    • 10.5.6.5. Rest of Asia-Pacific
• 10.6. Middle East and Africa
  • 10.6.1. Introduction
  • 10.6.2. Key Region-Specific Dynamics
  • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material Type
  • 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

11. Competitive Landscape

• 11.1. Competitive Scenario
• 11.2. Market Positioning/Share Analysis
• 11.3. Mergers and Acquisitions Analysis

12. Company Profiles

• 12.1. Medtronic Inc *
  • 12.1.1. Company Overview
  • 12.1.2. Product Portfolio & Description
  • 12.1.3. Financial Overview
  • 12.1.4. Key Developments
• 12.2. BD
• 12.3. Smiths Medical
• 12.4. Edwards Lifesciences Corporation
• 12.5. Cook Medical
• 12.6. Cardinal Health
• 12.7. Coloplast
• 12.8. CIA Medical
• 12.9. Getinge
• 12.10. Medical, Inc

LIST NOT EXHAUSTIVE

13. Appendix

• 13.1. About Us and Services
• 13.2. Contact Us